The effect of weight loss on recurrence of atrial fibrillation after catheter ablation: A systematic review and meta‐analysis

Author:

Akhtar Khawaja Hassan1,Jafry Ali Haider2ORCID,Beard Christopher3,Nasir Yusra Minahil3,Agarwal Siddharth3,Khan Jehanzeb1,Clifton Shari4,Reece Jessica5,Munir Muhammad Bilal6,Deshmukh Abhishek7ORCID,DeSimone Christopher V.7ORCID,Jackman Warren M.1,Stavrakis Stavros1ORCID,Po Sunny1,Sanders Prashanthan8ORCID,Asad Zain Ul Abideen1ORCID

Affiliation:

1. Department of Medicine, Section of Cardiovascular Medicine University of Oklahoma Health Sciences Center Oklahoma City Oklahoma USA

2. Department of Medicine, Section of Cardiovascular Medicine Allegheny General Hospital Pittsburgh Pennsylvania USA

3. Department of Medicine University of Oklahoma Health Sciences Center Oklahoma City Oklahoma USA

4. Robert M. Bird Health Sciences Library University of Oklahoma Health Sciences Center Oklahoma City Oklahoma USA

5. Department of Biostatistics and Epidemiology University of Oklahoma Health Sciences Center Oklahoma City Oklahoma USA

6. Division of Cardiovascular Medicine University of California Davis Sacramento California USA

7. Department of Cardiovascular Medicine Mayo Clinic Rochester Minnesota USA

8. University of Adelaide and Royal Adelaide Hospital Adelaide Australia

Abstract

AbstractBackgroundObesity is associated with an increased risk of developing recurrent atrial fibrillation (AF) after catheter ablation (CA). However, the current data on weight loss interventions show inconsistent results in preventing the recurrence of AF after CA.MethodsWe conducted a systematic search in MEDLINE and EMBASE to identify studies that reported the outcome of recurrence of AF after CA in obese patients undergoing weight interventions. The subgroup analysis included: (1) Weight loss versus no weight loss, (2) >10% weight loss versus <10% weight loss, (3) <10% weight loss versus no weight loss, (4) Follow‐up <12 months, and (5) Follow‐up >12 months after CA. Mantel–Haenszel risk ratios with a 95% confidence interval (CI) were calculated using a random effects model and for heterogeneity, I2 statistics were reported.ResultsA total of 10 studies (one randomized controlled trial and nine observational studies) comprising 1851 patients were included. The recurrence of AF was numerically reduced in the weight loss group (34.5%) versus no weight loss group (58.2%), but no statistically significant difference was observed (risk ratio [RR] = 0.76; 95% CI: 0.49–1.18, p = .22). However, there was a statistically significant reduction in recurrence of AF with weight loss versus no weight loss at follow‐up >12 months after CA (RR = 0.47; 95% CI: 0.32–0.68, p < .0001). At follow‐up >12 months after CA, both >10% weight loss versus <10% weight loss (RR = 0.49; 95% CI: 0.31–0.80, p = .004) and <10% weight loss versus no weight loss (RR = 0.39; 95% CI: 0.31–0.49, p < .00001) were associated with a statistically significant reduction in recurrent AF.ConclusionIn patients with AF undergoing CA, weight loss is associated with reducing recurrent AF at > 12 months after ablation and these benefits are consistently seen with both >10% and <10% weight loss. The benefits of weight loss in preventing recurrent AF after CA should be examined in larger studies with extended follow‐up duration.

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3